- Home
- TIVC vs BDRX Comparison
TIVC vs BDRX Comparison
Compare TIVC & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIVC
- BDRX
- Stock Information
- Founded
- TIVC 2016
- BDRX 2000
- Country
- TIVC United States
- BDRX United Kingdom
- Employees
- TIVC N/A
- BDRX N/A
- Industry
- TIVC Biotechnology: Electromedical & Electrotherapeutic Apparatus
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- TIVC Health Care
- BDRX Health Care
- Exchange
- TIVC Nasdaq
- BDRX Nasdaq
- Market Cap
- TIVC 4.0M
- BDRX 3.8M
- IPO Year
- TIVC 2021
- BDRX N/A
- Fundamental
- Price
- TIVC $2.98
- BDRX $5.61
- Analyst Decision
- TIVC
- BDRX
- Analyst Count
- TIVC 0
- BDRX 0
- Target Price
- TIVC N/A
- BDRX N/A
- AVG Volume (30 Days)
- TIVC 3.1M
- BDRX 45.7K
- Earning Date
- TIVC 08-14-2025
- BDRX 09-29-2025
- Dividend Yield
- TIVC N/A
- BDRX N/A
- EPS Growth
- TIVC N/A
- BDRX N/A
- EPS
- TIVC N/A
- BDRX N/A
- Revenue
- TIVC $462,000.00
- BDRX N/A
- Revenue This Year
- TIVC N/A
- BDRX N/A
- Revenue Next Year
- TIVC N/A
- BDRX N/A
- P/E Ratio
- TIVC N/A
- BDRX N/A
- Revenue Growth
- TIVC N/A
- BDRX N/A
- 52 Week Low
- TIVC $2.43
- BDRX $5.00
- 52 Week High
- TIVC $15.64
- BDRX $112.85
- Technical
- Relative Strength Index (RSI)
- TIVC 39.13
- BDRX 36.59
- Support Level
- TIVC $2.81
- BDRX $5.00
- Resistance Level
- TIVC $3.19
- BDRX $5.96
- Average True Range (ATR)
- TIVC 0.18
- BDRX 0.51
- MACD
- TIVC -0.00
- BDRX 0.03
- Stochastic Oscillator
- TIVC 20.00
- BDRX 30.96
About TIVC Tivic Health Systems Inc.
Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.